tiprankstipranks

CURE Price & Analysis

Compare

CURE ETF Chart & Stats

ETF Overview

Direxion Daily Healthcare Bull 3x Shares

CURE provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies.
Asset Class
Equity
Region
North America
Issuer
Direxion
Index Tracked
Health Care Select Sector
Ticker Symbol
CURE

Direxion Daily Healthcare Bull 3x Shares (CURE) Fund Flow Chart

Direxion Daily Healthcare Bull 3x Shares (CURE) 1 year Net Flows: -4M

CURE ETF FAQ

What was CURE’s price range in the past 12 months?
CURE lowest ETF price was 88.21 and its highest was 143.51 in the past 12 months.
    What is the AUM of CURE?
    As of Jan 27, 2025 The AUM of CURE is 189.40M.
      Is CURE overvalued?
      Not enough analysts have published a price target to calculate whether the price is overvalued.
      Does CURE pay dividends?
      CURE pays a Quarterly dividend of 0.115 which represents an annual dividend yield of 0.96%. See more information on CURE dividends here
        How many shares outstanding does CURE have?
        CURE has 1,800,008 shares outstanding.
          Which hedge fund is a major shareholder of CURE?
          Currently, no hedge funds are holding shares in CURE

          Top 10 Holdings

          Name
          Weight %
          USD_CASH
          U.S. Dollar
          20.79%
          Eli Lilly And Company
          9.46%
          Unitedhealth Group Inc.
          7.43%
          Johnson & Johnson
          5.47%
          Abbvie
          4.64%
          Merck & Company
          3.68%
          Abbott Laboratories
          3.33%
          Thermo Fisher Scientific
          3.32%
          Intuitive Surgical
          3.03%
          Danaher Corporation
          2.39%
          Total63.55%
          See All Holdings
          Popular ETFs
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis